Interview with Nancy Carpenter
The COVID-19 pandemic has put pharmaceutical research firmly into the spotlight, with the urgent need to develop new therapies, tests, and vaccines. For those outside the industry, hearing announcements in the mainstream media, it is not always easy to understand the intensity of the work and collaboration that fuels game-changing new developments.
However, we know that there are thousands of ‘unsung heroes’ around the world, working in different capacities on different clinical trials to make the breakthrough. It has been a herculean collective effort. Of course, while this is a particularly high stakes situation, seeing an impact on patients’ lives motivates us no matter the therapeutic area. In this podcast, I interview Nancy Carpenter, a Principal Statistician at Veramed who has worked extensively on COVID-19 trials over the last several months. Our wide-ranging discussion covers:
- Her experience of working on COVID-19 trials
- How patient stories inspire her
- How we balance risks and manage the impact of COVID-19 on other clinical trials
- How a role in pharma provides meaning and fulfilment
- How the pandemic has increased public interest in the pharmaceutical industry
Nancy has been working in the Pharma industry for over 20 years. She has worked in both Pharma and CROs in both contract and permanent roles. She is currently working at Veramed – a CRO specialising in biometrics, where she provides statistical consultancy services to several smaller Pharma companies and leading the statistics side of several reporting projects.
Listen to this episode now and share this to your friends and colleagues!